PreCyte, the first precision medicine tool for a new standard of care
PreCyte SSI transforms how we predict and manage surgical risks
Preoperative
PreCyte enables prediction of complications with a simple blood test, identifying patients who would benefit from preoperative interventions such as prehab or optimization of the approach, technique, and timing of surgery. The PreCyte test can be repeated after preoperative interventions (prehab or neoadjuvant treatment), allowing the healthcare team to monitor their effectiveness and continually assess surgical readiness throughout the preoperative period.
Postoperative
PreCyte combines clinical data from the surgery with the patient's immune response to the surgical trauma the day after surgery to guide patient monitoring, discharge timing, and anticipation and prevention of complications. By accelerating discharge of patients at low-risk for complications, the risk of hospital-acquired infections is decreased and the economic burden of lengthy hospital stays is eased.
With 63 million elective surgeries performed each year in the US, and a 30% complication rate for major surgeries, the impact on patient morbidity and healthcare systems can be devastating: extended hospital stays, readmissions, patient suffering, disability, and even death.
Knowledge of individual risk to predict and prevent complications improves patient outcomes and allows for a surgical risk-adapted length of hospital stay, shifting care towards the outpatient setting. Preventing complications and shortening hospital stays saves billions of dollars in healthcare spending.
PreCyte Surgical’s software platform analyzes the medicoeconomicimpact of incorporating its use at various points in the care pathway.
Develop your actionable
Monitor the efficacy of your actionable
